The Nevro Senza, as shown in a video on the company's website. Nevro’s stock is now up more than 20% from where it was late last week, after the Menlo Park, CA–based company said that the FDA has deemed the PMA for its spinal ...
Tags: spinal pain-killing device, Health
The EnterMedics Maestro Rechargeable System weight loss treatment device is effective although scientists are unclear why. The FDA has approved the first weight-loss device since 2007, giving obese adults an alternative to dieting and ...
China will become the world's second-largest medical technology market with a value of $55 billion by 2020, The Boston Consulting Group said in a report released on Wednesday. The medtech market, including instruments and equipment, ...
Tags: medical technology, medical device
Patients with spinal cord injuries and other forms of paralysis have reason to be optimistic, thanks to recent advances in the use of spinal-cord stimulator devices to regain some lower limb function. A recently announced study reporting ...
Medtech giant St. Jude Medical announced a major reorganization and leadership changes on Tuesday. The Little Canada, MN–based company says its two operating divisions will be integrated into one research and development ...
St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the fourth quarter and full year ended Dec. 28, 2013. Fourth quarter highlights: Net sales increased by approximately 6 percent on a constant-currency basis ...
Tags: CRM, AF, Neuromodulation, St.Jude Medical
For the medtech industry, 2014 is unlikely to be a year full of surprises as companies grapple with a health care market wary of big-ticket procedures and items. The largest gains will likely involve digital health and other technologies ...
Boston Scientific has reported favorable results assessing real-world experience with the Precision Spectra spinal cord stimulator system. New retrospective data highlighting the Boston Scientific Precision Spectra spinal cord stimulator ...
US-based Boston Scientific has obtained CE Mark approval for its Vercise deep brain stimulation (DBS) system for the treatment of intractable primary and secondary dystonia. Dystonia is a neurological movement disorder characterized by ...
Tags: Dystonia Treatment, DBS System
Medtronic, a US-based developer of medical devices, has introduced its new implantable neurostimulation systems, also called spinal cord stimulation (SCS) systems, for use in the treatment of chronic, intractable back and limb pain that are ...
US-based medical technology provider Boston Scientific has commenced a clinical trial to evaluate whether occipital nerve stimulation (ONS) using the Precision System can safely and effectively treat chronic migraine when used in ...
Boston Scientific has received CE Mark approval for use of the GUIDE DBS System, a deep brain stimulation (DBS) visual simulation system. GUIDE DBS offers clinicians with 3D visualization information that simulates stimulation output, ...
Tags: CE Mark, DBS System
US-based medical device manufacturer Boston Scientific has introduced fiXate Tissue Band in the US. The product, which was purchased from Anulex Technologies, is a suturing device that is designed to enable simple placement of a suture to ...
Tags: Boston Scientific, Fixate Tissue
Fukuda Denshi, a manufacturer of medical electronics equipment, has entered into an agreement to market and sell Boston Scientific's neuromodulation device and accessories throughout Japan. Under the agreement, Fukuda will distribute ...
Tags: medical electronics, Scientific neuromodulation device, Fukuda
Therapeutic Goods Administration in Australia and the National Institute of Surveillance of Medicine and Foods in the Ministry of Health in Colombia have approved ElectroCore's non-invasive, non-pharmaceutical vagus nerve stimulation ...
Tags: ElectroCore, Therapeutic Goods, Medicine